IOVA INVESTOR NOTICE: Iovance Biotherapeutics, Inc. Investors with Losses are Notified of the Ongoing Securities Fraud Class Action and July 14 Deadline – BFA Law (NASDAQ:IOVA)

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/iovance-biotherapeutics-inc-class-action-lawsuit. Investors have until July 14, 2 ...